Literature DB >> 7584483

Interleukin-I antagonists.

S K Dower1, W Fanslow, C Jacobs, S Waugh, J E Sims, M B Widmer.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7584483

Source DB:  PubMed          Journal:  Ther Immunol        ISSN： 0967-0149


× No keyword cloud information.
  6 in total

Review 1.  The use of anakinra in juvenile arthritis.

Authors:  Andreas Reiff
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

2.  High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries.

Authors:  S D Yanofsky; D N Baldwin; J H Butler; F R Holden; J W Jacobs; P Balasubramanian; J P Chinn; S E Cwirla; E Peters-Bhatt; E A Whitehorn; E H Tate; A Akeson; T L Bowlin; W J Dower; R W Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation.

Authors:  T Rauschmayr; R W Groves; T S Kupper
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

Review 4.  Treatment of rheumatoid arthritis with IL-1 inhibitors.

Authors:  C Gabay; W P Arend
Journal:  Springer Semin Immunopathol       Date:  1998

Review 5.  Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma.

Authors:  V H van der Velden
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

6.  Pharmacokinetics of Azalomycin F, a Natural Macrolide Produced by Streptomycete Strains, in Rats.

Authors:  Su He; Wenjia Zhao; Peibo Li; Wenqing Tu; Kui Hong; Duoduo Zhang; Tongke Zhang; Ganjun Yuan
Journal:  Molecules       Date:  2021-10-26       Impact factor: 4.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.